Skip to main content
ZJAMP Group Co., Ltd. logo

ZJAMP Group Co., Ltd. — Investor Relations & Filings

Ticker · 002758 ISIN · CNE100002029 LEI · 3003009OKT32LB5C0T64 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,563 across all filing types
Latest filing 2020-05-17 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 002758

About ZJAMP Group Co., Ltd.

https://www.znjtgf.com

ZJAMP Group Co., Ltd. specializes in the comprehensive distribution and supply chain management of agricultural production materials. The company’s core operations encompass the procurement, storage, and sale of essential inputs, including chemical fertilizers such as urea, potash, and compound fertilizers, as well as pesticides, seeds, and agricultural machinery. Beyond product distribution, the organization provides integrated technical services, modern logistics solutions, and agricultural consultancy to enhance crop yields and farming efficiency. By leveraging an extensive network of distribution centers and service stations, the group facilitates the stable supply of high-quality agricultural resources. Its business model focuses on bridging the gap between manufacturers and end-users through efficient resource allocation and value-added services.

Recent filings

Filing Released Lang Actions
关于“华通转债”转股价格调整的公告
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Zhejiang Huatong Pharmaceutical Co., Ltd. regarding the adjustment of the conversion price of its convertible bonds (华通转债). It details the adjustment formula, the previous and new conversion prices, and the effective date of the adjustment. The content focuses on a capital structure change related to convertible bonds, specifically the adjustment of the conversion price due to dividend distribution. There is no financial statement or comprehensive report included, only an announcement of a capital change event. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is short (1321 characters), consistent with an announcement rather than a full report.
2020-05-17 Chinese
发行股份购买资产暨关联交易报告书(草案)(修订稿)摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed report concerning a major asset restructuring transaction by Zhejiang Huatong Pharmaceutical Co., Ltd. It includes extensive information about the issuance of shares to purchase assets, related party transactions, financial data, audit reports, valuation reports, and legal opinions. The document references specific dates, financial figures, and regulatory requirements related to a significant asset acquisition and restructuring. It is not a brief announcement or a simple notice but a comprehensive report on a capital transaction involving issuance of shares and asset purchase. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising, financing activities, and capital structure changes related to the issuance of shares for asset purchase and restructuring. The document length and content confirm it is not a mere announcement or certification but a substantive report on the financing transaction.
2020-05-12 Chinese
独立董事关于公司第四届董事会第五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion statement from the independent directors of Zhejiang Huatong Pharmaceutical Co., Ltd. regarding matters discussed at the company's fourth board of directors' fifth meeting. It specifically addresses approval of proposals related to a major asset restructuring, including supplementary audit reports, evaluation reports, and related transaction reports. The document references compliance with laws and regulations, the fairness of procedures, and the benefits of the restructuring to shareholders. It is not a full audit report, annual report, or financial statement, but rather an independent directors' opinion on board meeting matters related to a major asset restructuring. This fits best under Board/Management Information (MANG), which covers announcements of changes or significant board-related decisions. The document length is short (1061 characters), and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2020-05-12 Chinese
备考审计报告及财务报表(2018年度-2019年度)
Regulatory Filings
2020-05-12 Chinese
发行股份购买资产暨关联交易报告书(草案)(修订稿)
Regulatory Filings
2020-05-12 Chinese
浙农集团股份有限公司审计报告及财务报表(2017年度-2019年度)
Regulatory Filings
2020-05-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.